Sei Investments CO Verastem, Inc. Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.33 - $10.44 $2,319 - $73,382	7,029 Added 35.77%	26,678 $10,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $5,363 - $9,622	-5,258 Reduced 21.11%	19,649 $23,000
Q2 2021 Aug 06, 2021	BUY	$2.57 - $4.85 $64,010 - $120,798	24,907 New	24,907 $101,000
Q3 2018 Nov 08, 2018	SELL	$6.86 - $9.97 $833,078 - $1.21 Million	-121,440 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$2.88 - $8.67 $347,745 - $1.05 Million	120,745 Added 17373.38%	121,440 $836,000
Q1 2018 May 11, 2018	BUY	$2.92 - $3.81 $2,029 - $2,647	695 New	695 $2,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.